Clinical Trial Update: Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial comparing fulvestrant plus palbociclib versus tamoxifen plus palbociclib in metastatic breast cancer is completed, with results posted on 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Palbociclib (palbociclib)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Shannon Puhalla | Conditions: Metastatic Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-09-23